These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 21999369)

  • 21. Irbesartan for the treatment of hypertension in patients with the metabolic syndrome: a sub analysis of the Treat to Target post authorization survey. Prospective observational, two armed study in 14,200 patients.
    Kintscher U; Bramlage P; Paar WD; Thoenes M; Unger T
    Cardiovasc Diabetol; 2007 Apr; 6():12. PubMed ID: 17407587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Short-term treatment with metformin improves the cardiovascular risk profile in first-degree relatives of subjects with type 2 diabetes mellitus who have a metabolic syndrome and normal glucose tolerance without changes in C-reactive protein or fibrinogen.
    Lima LM; Wiernsperger N; Kraemer-Aguiar LG; Bouskela E
    Clinics (Sao Paulo); 2009 May; 64(5):415-20. PubMed ID: 19488607
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation of cardio-metabolic parameters with vitamin D status in healthy premenopausal women.
    Giovinazzo S; Alibrandi A; Campennì A; Trimarchi F; Ruggeri RM
    J Endocrinol Invest; 2017 Dec; 40(12):1337-1343. PubMed ID: 28616825
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic syndrome and arterial pulse wave velocity.
    Kim YJ; Kim YJ; Cho BM; Lee S
    Acta Cardiol; 2010 Jun; 65(3):315-21. PubMed ID: 20666270
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Central or peripheral systolic or pulse pressure: which best relates to target organs and future mortality?
    Wang KL; Cheng HM; Chuang SY; Spurgeon HA; Ting CT; Lakatta EG; Yin FC; Chou P; Chen CH
    J Hypertens; 2009 Mar; 27(3):461-7. PubMed ID: 19330899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toe brachial index predicts major acute cardiovascular events in patients with type 2 diabetes independently of arterial stiffness.
    Chisalita SI; Wijkman M; Davidson LT; Spångeus A; Nyström F; Östgren CJ
    Diabetes Res Clin Pract; 2020 Mar; 161():108040. PubMed ID: 32006647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protocol for measuring carotid intima-media thickness that best correlates with cardiovascular risk and target organ damage.
    Gómez-Marcos MA; Recio-Rodríguez JI; Patino-Alonso MC; Agudo-Conde C; Gómez-Sanchez L; Gómez-Sanchez M; Rodríguez-Sánchez E; García-Ortiz L
    Am J Hypertens; 2012 Sep; 25(9):955-61. PubMed ID: 22717546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk markers for later cardiovascular diseases in liver-transplanted children and adolescents.
    Naeser V; Brandt AH; Nyhuus B; Borgwardt L; Jørgensen MH; Rasmussen A
    Pediatr Transplant; 2018 Dec; 22(8):e13298. PubMed ID: 30338616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Relationship of arterial wall parameters to cardiovascular risk factors and cardiovascular risk assessed by SCORE system].
    Kovaite M; Petrulioniene Z; Ryliskyte L; Badariene J; Cypiene A; Dzenkeviciūte V; Laucevicius A
    Medicina (Kaunas); 2007; 43(7):529-41. PubMed ID: 17768367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Age-dependent systemic DNA damage in early Type 2 Diabetes mellitus.
    Rogulj D; El Aklouk I; Konjevoda P; Ljubić S; Pibernik Okanović M; Barbir A; Luburić M; Radman M; Budinski N; Vučić Lovrenčić M
    Acta Biochim Pol; 2017; 64(2):233-238. PubMed ID: 28350403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating TNFrII levels predict incidence of ischemic heart disease and total mortality, independently of intima media thickness and pulse wave velocity in male with type 2 diabetes.
    Johansson MA; Vavruch C; Östgren CJ; Nystrom FH
    Heart Vessels; 2021 Oct; 36(10):1591-1596. PubMed ID: 33871700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between Serum Uric Acid and Vascular Function and Structure Markers and Gender Difference in a Real-World Population of China-From Beijing Vascular Disease Patients Evaluation Study (BEST) Study.
    Liu H; Liu J; Zhao H; Zhou Y; Li L; Wang H;
    J Atheroscler Thromb; 2018 Mar; 25(3):254-261. PubMed ID: 28904249
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolic syndrome may be associated with increased arterial stiffness even in the absence of hypertension: a study in 84 cases and 82 controls.
    Kangas P; Tikkakoski AJ; Tahvanainen AM; Leskinen MH; Viitala JM; Kähönen M; Kööbi T; Niemelä OJ; Mustonen JT; Pörsti IH
    Metabolism; 2013 Aug; 62(8):1114-22. PubMed ID: 23557592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between ambulatory arterial stiffness index and subclinical target organ damage in hypertensive patients.
    García-García A; Gómez-Marcos MA; Recio-Rodriguez JI; González-Elena LJ; Parra-Sanchez J; Fe Muñoz-Moreno M; Alonso CP; Gude F; García-Ortiz L
    Hypertens Res; 2011 Feb; 34(2):180-6. PubMed ID: 20962781
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The association of metabolic syndrome and its components with brachial-ankle pulse wave velocity in south China.
    Chen L; Zhu W; Mai L; Fang L; Ying K
    Atherosclerosis; 2015 Jun; 240(2):345-50. PubMed ID: 25875386
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between macro- and microvascular damage and the triglyceride glucose index in community-dwelling elderly individuals: the Northern Shanghai Study.
    Zhao S; Yu S; Chi C; Fan X; Tang J; Ji H; Teliewubai J; Zhang Y; Xu Y
    Cardiovasc Diabetol; 2019 Jul; 18(1):95. PubMed ID: 31345238
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tofogliflozin long-term effects on atherosclerosis progression and major clinical parameters in patients with type 2 diabetes mellitus lacking a history of cardiovascular disease: a 2-year extension study of the UTOPIA trial.
    Katakami N; Mita T; Yoshii H; Shiraiwa T; Yasuda T; Okada Y; Kurozumi A; Hatazaki M; Kaneto H; Osonoi T; Yamamoto T; Kuribayashi N; Maeda K; Yokoyama H; Kosugi K; Ohtoshi K; Hayashi I; Sumitani S; Tsugawa M; Ryomoto K; Kato K; Nakamura T; Kawashima S; Sato Y; Watada H; Shimomura I;
    Cardiovasc Diabetol; 2023 Jun; 22(1):143. PubMed ID: 37349722
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Orthostatic Blood Pressure Changes and Subclinical Markers of Atherosclerosis.
    Takahashi M; Miyai N; Nagano S; Utsumi M; Oka M; Yamamoto M; Shiba M; Uematsu Y; Nishimura Y; Takeshita T; Arita M
    Am J Hypertens; 2015 Sep; 28(9):1134-40. PubMed ID: 25673039
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Uric Acid, Metabolic Syndrome and Atherosclerosis: The Chicken or the Egg, Which Comes First?
    De Pergola G; Cortese F; Termine G; Meliota G; Carbonara R; Masiello M; Cortese AM; Silvestris F; Caccavo D; Ciccone MM
    Endocr Metab Immune Disord Drug Targets; 2018; 18(3):251-259. PubMed ID: 29437024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of the triglyceride-glucose index and vascular target organ damage in a Beijing community-based population.
    Ji W; Gao L; Sun P; Jia J; Li J; Wang X; Fan F; Zhang Y
    Front Cardiovasc Med; 2022; 9():948402. PubMed ID: 35966556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.